KURE vs VXUS
KraneShares MSCI All China Health Care Index ETF vs Vanguard Total International Stock ETF
Which is better, KURE or VXUS?
Large Cap Growth against Large Cap Blend.
VXUS has a lower expense ratio. VXUS led over 1Y, 3Y, 5Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | KURE | VXUS |
|---|---|---|
| Expense Ratio | 0.65% | 0.05%Best |
| AUM | $110M | $158.1B |
| Dividend Yield | 4.16% | 2.59% |
| Holdings | 54 | 8,747 |
| YTD Return | +8.68% | +16.15%Best |
| 1Y Return | -4.17% | +27.58%Best |
| 3Y Return (annualized) | +4.69% | +20.48%Best |
| 5Y Return (annualized) | -9.30% | +9.09%Best |
| Volatility (annualized) | 28.1% | 15.8%Best |
| Max Drawdown | -68.5% | -38.8%Best |
| $10,000 over 5 years | $6,138 | $15,450Best |
| Fund Family | KraneShares | Vanguard (US) |
| Category | Equity | Equity |
| Style | Large Cap Growth | Large Cap Blend |
| Inception | Jan 31, 2018 | Jan 26, 2011 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown are measured over the window both funds cover: Feb 1, 2018 to Sep 4, 2026 (8.6 years).
KURE vs VXUS growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 8.6 years both funds cover.
KURE vs VXUS Performance
KraneShares MSCI All China Health Care Index ETF (KURE) is an ETF from KraneShares and Vanguard Total International Stock ETF (VXUS) is an ETF from Vanguard (US). Over the past year KURE returned -4.17% while VXUS returned +27.58%. Year to date, KURE is up 8.68% versus a gain of 16.15% for VXUS.
Over three years, KURE compounded at +4.69% per year against +20.48% for VXUS; over five years the annualized figures are -9.30% and +9.09% respectively. Across the full 9-year window we track, VXUS has the edge at +6.67% annualized vs -0.83%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
KURE has been the more volatile fund, with annualized monthly volatility of 28.1% compared with 15.8% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -68.5% for KURE and -38.8% for VXUS. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.36. They move together some of the time, and apart the rest.
Fees and Cost Over Time
KURE charges 0.65% per year while VXUS charges 0.05%. On a $10,000 position that is $65 vs $5 annually, a gap of $60 per year that compounds over a long holding period. On income, KURE currently yields 4.16% against 2.59% for VXUS.
Holdings Overlap
At least 91.6% of KURE's money is in holdings VXUS also owns.
Stated as a floor: for VXUS, our book for it covers 87.7% of that fund, so a holding it does not list is one we cannot count as shared. The real figure is this or higher.
Most of KURE is already inside VXUS. Owning both mostly buys the same companies twice.
38 positions in common, counted across the 45 positions we hold weights for in KURE and 8,094 in VXUS, against full books of 54 and 8,747.
Top Shared Holdings
| Stock | Weight in KURE | Weight in VXUS | Difference |
|---|---|---|---|
| 6160:HKBeigene Ag | 9.48% | 0.04% | 9.44% |
| 1801:HKInnovent Biologics Inc | 8.70% | 0.04% | 8.66% |
| 2269:HKWuxi Biologics (cayman) Inc. | 8.41% | 0.04% | 8.37% |
| 603259:SHWuxi Apptec Co. Ltd. Class A | 6.26% | 0.01% | 6.25% |
| 300760:SHShenzhen Mindray Bio-Medical Electronic | 4.09% | 0.00% | 4.09% |
| 600276:SHJiangsu Hengrui Medicine Co Ltd | 4.05% | 0.01% | 4.04% |
| 9926:HKGAkeso,inc | 3.81% | 0.02% | 3.79% |
| 2359:HKWuxi Apptec Co Ltd | 3.66% | 0.02% | 3.64% |
| 1093:HKCSPC Pharmaceutical Group Limited Shs | 3.55% | 0.02% | 3.53% |
| 1177:HKSino Biopharmaceutical Limited Shs | 3.22% | 0.01% | 3.21% |
91.6% of KURE is already inside VXUS.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, KURE or VXUS?
KURE has an expense ratio of 0.65% while VXUS charges 0.05%. VXUS is the cheaper option, by $60 a year on a $10,000 investment.
Which performed better, KURE or VXUS?
Over the past year KURE returned -4.17% vs +27.58% for VXUS, so VXUS leads on 1-year performance. Over the longest common window we track (9 years), KURE annualized -0.83% vs +6.67% for VXUS. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, KURE or VXUS?
KURE has been the more volatile fund at 28.1% annualized versus 15.8% for VXUS. Worst drawdown: KURE -68.5% vs VXUS -38.8%.
Should I hold both KURE and VXUS?
KURE and VXUS have a monthly-return correlation of 0.36, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between KURE and VXUS?
At least 91.6% of KURE's money is in holdings VXUS also owns. Our book for VXUS is partial, so the real figure is this or higher. They hold 38 positions in common, counted across the 45 positions we hold weights for in KURE and 8,094 in VXUS.
Which pays a higher dividend, KURE or VXUS?
KURE yields 4.16% while VXUS yields 2.59%, so KURE currently pays the higher dividend yield.
Is VXUS better than KURE?
VXUS has a lower expense ratio. VXUS led over 1Y, 3Y, 5Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.